MEDICINOVA, INC. Earnings Per Share (Diluted)
MEDICINOVA, INC. (MNOV) reported Earnings Per Share (Diluted) of -$0.05 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-13
- MEDICINOVA, INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.05.
- MEDICINOVA, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.05.
- MEDICINOVA, INC. earnings per share, diluted for the quarter ending 2025-12-31 was $0.43, a 9.74% increase year-over-year.
- MEDICINOVA, INC. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.06.
- MEDICINOVA, INC. earnings per share, diluted for fiscal 2025 was -$0.24.
- MEDICINOVA, INC. earnings per share, diluted for fiscal 2024 was -$0.23.
- MEDICINOVA, INC. earnings per share, diluted for fiscal 2023 was -$0.17.
- MEDICINOVA, INC. earnings per share, diluted for fiscal 2022 was -$0.29.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.05 10-Q · filed 2026-08-13 | -$0.10 10-Q · filed 2026-08-13 | $0.33 derived: net income ÷ weighted average shares · filed 2026-08-13 | $0.27 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2026-03-31 | -$0.05 10-Q · filed 2026-05-14 | $0.38 derived: net income ÷ weighted average shares · filed 2026-08-13 | $0.32 derived: net income ÷ weighted average shares · filed 2026-08-13 | $0.25 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-12-31 | $0.43 derived: net income ÷ weighted average shares · filed 2026-04-29 | $0.37 derived: net income ÷ weighted average shares · filed 2026-04-29 | $0.30 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.24 10-K · filed 2026-03-10 |
| 2025-09-30 | -$0.06 10-Q · filed 2025-11-12 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.19 10-Q · filed 2025-11-12 | $0.21 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-06-30 | -$0.07 10-Q · filed 2026-08-13 | -$0.13 10-Q · filed 2026-08-13 | $0.27 derived: net income ÷ weighted average shares · filed 2026-08-13 | $0.21 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-03-31 | -$0.06 10-Q · filed 2026-05-14 | $0.33 derived: net income ÷ weighted average shares · filed 2026-08-13 | $0.28 derived: net income ÷ weighted average shares · filed 2026-08-13 | $0.22 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2024-12-31 | $0.39 derived: net income ÷ weighted average shares · filed 2026-04-29 | $0.34 derived: net income ÷ weighted average shares · filed 2026-04-29 | $0.28 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.23 10-K · filed 2026-03-10 |
| 2024-09-30 | -$0.06 10-Q · filed 2025-11-12 | -$0.11 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.17 10-Q · filed 2025-11-12 | $0.14 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2024-06-30 | -$0.05 10-Q · filed 2025-08-14 | -$0.11 10-Q · filed 2025-08-14 | $0.20 derived: net income ÷ weighted average shares · filed 2026-04-29 | $0.18 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2024-03-31 | -$0.06 10-Q · filed 2025-05-13 | $0.25 derived: net income ÷ weighted average shares · filed 2026-04-29 | $0.24 derived: net income ÷ weighted average shares · filed 2026-04-29 | $0.18 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2023-12-31 | $0.31 derived: net income ÷ weighted average shares · filed 2026-04-29 | $0.29 derived: net income ÷ weighted average shares · filed 2026-04-29 | $0.23 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.17 10-K · filed 2025-02-19 |
| 2023-09-30 | -$0.01 10-Q · filed 2024-11-13 | -$0.07 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.13 10-Q · filed 2024-11-13 | -$0.19 derived: net income ÷ weighted average shares · filed 2024-11-13 |
| 2023-06-30 | -$0.06 10-Q · filed 2024-08-08 | -$0.12 10-Q · filed 2024-08-08 | -$0.18 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.25 derived: net income ÷ weighted average shares · filed 2024-11-13 |
| 2023-03-31 | -$0.06 10-Q · filed 2024-05-09 | -$0.12 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.20 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.28 derived: net income ÷ weighted average shares · filed 2024-11-13 |
| 2022-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2024-02-15 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-02-15 | -$0.22 derived: net income ÷ weighted average shares · filed 2024-02-15 | -$0.29 10-K · filed 2024-02-15 |
| 2022-09-30 | -$0.07 10-Q · filed 2023-11-09 | -$0.16 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.23 10-Q · filed 2023-11-09 | -$0.27 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-06-30 | -$0.08 10-Q · filed 2023-08-09 | -$0.15 10-Q · filed 2023-08-09 | -$0.19 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.27 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-03-31 | -$0.07 10-Q · filed 2023-05-11 | -$0.11 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.18 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.27 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2021-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$0.12 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$0.20 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$0.21 10-K/A · filed 2023-03-28 |
| 2021-09-30 | -$0.07 10-Q · filed 2022-11-10 | -$0.16 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.17 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$0.09 10-Q · filed 2022-08-11 | -$0.09 10-Q · filed 2022-08-11 | ||
| 2013-12-31 | $0.14 10-K · filed 2015-03-12 | |||
| 2013-09-30 | -$0.10 10-K · filed 2015-03-12 | |||
| 2013-06-30 | -$0.14 10-K · filed 2015-03-12 | |||
| 2013-03-31 | -$0.14 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |